Please assess the completion status of the following clinical trial:

Trial Title: Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects who completed induction studies A3921094 or A3921095 and were classified as not meeting clinical response criteria; OR~* Subjects who completed maintenance study A3921096 or who discontinued treatment early in Study A3921096 due to treatment failure.~Exclusion Criteria:~* Subjects who had a major protocol violation in Study A3921094, A3921095 or A3921096.~* Presence of indeterminate colitis, microscopic colitis, ischemic colitis, infectious colitis, or clinical findings suggestive of Crohn's disease.~* Subjects who have had surgery for ulcerative colitis or in the opinion of the investigator, are likely to require surgery for ulcerative colitis during the study period.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CP-690,550 5 mg BID (Type: EXPERIMENTAL): 5 mg BID
- CP-690,550 10 mg BID (Type: EXPERIMENTAL): 10 mg BID

Based on this trial design, predict the completion outcome and termination type (if applicable).